You right , and after thinking little longer about , protocol should be different .,
Patients in placebo should stay also on HAART for the first week with Leronlimab .,
But this is normal with every studies .,
We always know how should be done after is done...)

Yes it will be good to know when they have most failures , if early in the study then one week difference with Leronlimab will make a difference , if later , this should not be a reason..
I have a feeling it happened early ..,